Enclosed herewith Audited Financial Results for the quater and year ended on March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Daikaffil Chemicals India reported revenue of Rs. 1,334.75 lakhs for FY2026, a significant jump from Rs. 749.84 lakhs in FY2025 (78% increase), driven by higher sales volumes in its OBA and chemicals business. However, the company posted a net loss of Rs. 214.07 lakhs (standalone) compared to Rs. 158.98 lakhs the prior year, widening by about 35% as expenses grew faster than revenue. Total assets nearly halved from Rs. 1,441.29 lakhs to Rs. 968.89 lakhs, and other equity fell sharply from Rs. 285.22 lakhs to Rs. 73.77 lakhs, indicating substantial erosion of reserves. Operating cash flow turned positive at Rs. 54.72 lakhs from negative Rs. 629.91 lakhs, largely due to a sharp reduction in trade receivables. The company also prepared consolidated results for the first time after setting up a subsidiary, Mikusu Global Industries Limited, in August 2025. Statutory auditors issued an unmodified (clean) opinion.
The near-doubling of revenue is encouraging but the widening losses and collapsing equity base signal serious operational stress. Shareholders should monitor whether the company can achieve profitability at scale, as the cash position remains thin and reserves have been largely depleted.